Anti fertility activity of hydro alcoholic extract of Trillium govanianum in Ethinyl Estradiol induced anti fertility model in rats
DOI:
https://doi.org/10.22270/ajprd.v6i2.343Keywords:
Trillium govanianum, Ethinyl estradiol, fertility index, hydro alcoholic extractAbstract
Lack of fertility is in fertility were as anti-fertility is to reduce fertility. Fertility is burning issue of global as well as national public issue which are concerning the fast growth of the country. Increase rate of population has got and adverse effect on the economy of the countries. So there is an urgent and important need for the anti fertility services in the country. In present study anti implantation and anti estrogenic activity of hydro alcoholic extract of Trillium govanianum was evaluated in Ethinyl estradiol induced anti fertility model. Obtained result suggests that Trillium govanianum at the doses of 250 and 500 mg/kg body weight produced a dose dependent adverse effect on fertility index and number of implantation in the uterine horns of the female rats by virtue of an increase in the percentage of the post implantation embryonic loss. All the experimental extract when evaluated for their abortifacient activity, were found to exhibit pregnancy interceptive activity. Administration of 100 mg/kg body weight of the alcoholic extract resulted in 100% abortion, while doses of 250 and 500 mg/ kg body weight of the alcoholic extract resulted in 28.50% and 44.45% abortion. This was evident from decrease in the percentage of live fetuses. The percent resorption index increased from zero in the control animals to 100 % in 100 mg/kg body weight alcoholic extract treated animals.
Downloads
References
2. United Nation Development Programme(UNDP),Human Development Report 2000, Oxford University by
Press,Oxford UK, 2000.
3. G. Schwartsmann, M.J .Ratain,G.M.Cragg et al., Anticancer drug discovery and Development throughout the
world,” Journal of clinical Oncology, vol.20,no.18,pp-47-59,2002.
4. M.R. P.Rao, U.R Adagale, A. Shetty, P.Namjoshi, p.Gaitonde, and P,Jain, Cancer immunotherapy,2007
5. Merlocm, Pepper JW, Reid BJ, Maley Cancer as an evolutionary and ecological process. Nature Reviews Cancer . 6(12):924-35,2013.
6. Thun MJ, JemalA.Epidemiology of cancer.In Goldman L, Schafer AL, eds, Cecil medicine.Philadelphia,Pa Sunders
Elsevier ;2011 .
7. Dr. KirtiBushan ;Department of Surgical Oncology, Asian Institute of oncology.cell A Molecular Approach, 2nd
edition Cooper GM. Sunderland (MA) sinauer Associates ; 2000.
8. Moscow JA, Cowan KH, Biology of cancer.In Goldman L,SchaferAL,eds. Cecil Medicine, Philadelphia, Pa:
Sunders Elsevier; chap 185, 2011.
9. Dr. FaiquaAdenoidectomy: Surgery of Adenoid Tissue12;(21), 2011. The Goal of Cancer Treatment Balis FM
Oncologist .3(4 ) 1998.
10. American Cancer Society. Reviewed by Jennifer Robinson ,MD on January 12, 2016.
11. Wanjek ,Christopher, Exciting New Cancer Treatments Emerge Amid Persistent Myths. Retrieved 2009.
12. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, KesslerTrends in alternative medicine use
in the United States, 11;280(18):1569-75 1990- 1997
13. Gijtenbeek, J.M., Van den Bent, M.J. and Vecht, C.J., Cyclosporine neurotoxicity: A review. J.Neurol, Issue 246,
pp: 339-346, 1999
14. Johnson, W.C. and Williford, W.O. Benefits, morbidity and mortality associated with long term administration of
oral anti- coagulant therapy to patients with Peripheral arterial bypass procedures: A prospective randomized
study. J. Vasc. Surg. Issue 35,413-421, 2002.
15. Newman SB Haga, JM O’Daniel, GM Tindall, R Mill , I Lipkus and R Aganset al; 2012.
16. WHO Preventing chronic disease ; a vital investment, in WHI press. Geneva: WHO Global report ; 2015.
17. Mathers CD, Loncar D.PLO S Med. 3(1 ):442, 2006
18. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ.Global and regional burden of disease and risk factors,
systematic analysis populationhealth.data.Lancet.27;367(9524):1747-57, 2006.
19. Hoyert DL, Heron MP,Mulphysl, Kung H.C.Natl.Vital start. Rep. 54(13 ):1-120, 2006.
20. Lau BHS, Tadi PP, Tosk JM. Allium sativum (garlic) and cancer prevention. Nutr Res, Steinmetz KA, Kushi LH,
Bostick RM, Folsom AR, Potter JD.Vegetable, fruit, and colon cancer in the Iowa women's health study. Am J
Epidemiol. 139:1-15, 1994.
21. Pecere T, Gazzola MV, Micignat C, et al: Aloe-emodin is a new type of anticancer anticancer agent with selective
activity against neuro-ectodermal tumors.Cancer Res, 60:2800-2804, 2000.
22. M.R.P.Rao,U. RAdagale, A.Shetty,P.Namjoshi,p. Gaitonde, and P,Jain, cancer immuno therapy,2007.
23. NoureenN ,Kalsoom S and Rashid H. Ligand based pharmacophoremodelling of anti-cancer histone deacety lase
inhibitors. African Journal of Biotechnology Vol. 9(25), 3923-3931, 21 June, 2010.
24. C.J.Murray and A. Lepez, The Global Burden of Disease, Hardvard University press, Cambridge, UK, 1996.
25. United Nation Development Programme(UNDP),Human Development Report Oxford University by Press,Oxford
UK, 2000.
26. G. Schwartsmann, M.J .Ratain, G. M. Cragg et al., Anticancer drug discovery and development throughout the
world,” Journal of clinical Oncology, vol.20:18(47)59, 2002.
27. M. R. P. Rao, U. R Adagale, A. Shetty, P. Namjoshi, p. Gaitonde, and P, Jain, Cancer immune therapy, 2007.
28. Merlocm, Pepper JW, Reid BJ, Maley cc Cancer as an evolutionary and ecological process. Nature Reviews
Cancer . 6(12):924-35, 2006.
29. Thun MJ, Jemal A. Epidemiology of cancer. In Goldman L, Schafer AL, eds, Cecil medicine. Philadelphia, Pa
Sunders Elsevier183 ; (24) 2011
Published
How to Cite
Issue
Section
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.